Your Location:
Home >
Browse articles >
Effect of Yanghetang-containing Serum on Breast Cancer 4T1 Cells Based on MEK/ERK Signaling Pathway
Updated:2023-05-16
    • Effect of Yanghetang-containing Serum on Breast Cancer 4T1 Cells Based on MEK/ERK Signaling Pathway

    • YU Xiao , REN Cuicui , DOU Jianwei
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 29, Issue 12, Pages: 71-77(2023)
    • DOI: 10.13422/j.cnki.syfjx.202202323     

      CLC:

    Scan QR Code

  •  
  •  
  • Full Text(HTML)

  • Figs( 3 ) Tabs( 5 )

  • References

  • Publication Info

  • Metrics

Sections
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

186

Views

271

Downloads

2

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Screening of Anti-breast Cancer Active Ingredients in Famous Classical Formula Yanghetang
Effect of Extracts from on Cell Growth and Apoptosis of Breast Cancer Cells T47D
Mechanism of Chidamide Combined with Compound Kushen Injection on Breast Cancer Cells Based on Transcriptomics
In Vitro Anti-psoriatic Effect of Kangfuxin Liquid via Inhibiting Cell Proliferation and Migration Ability and Blocking JAK3/STAT3 Signaling Pathway
Discussion on Modern Development of Traditional Chinese Medicine Diagnosis Based on Artificial Intelligence

Related Author

SU Sijia
ZHAO Xinyu
ZHOU Jingna
GAO Junfeng
TANG Xu
WEN Binyu
WANG Jian
CHEN Rong-chang

Related Institution

Dongfang Hospital, Beijing University of Chinese Medicine
College of Pharmacy, Gansu University of Chinese Medicine
Gansu Provincial People's Hospital
Frontier Science Center for Transformative Molecules, Shanghai Jiao Tong University
Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&D, College of Pharmacy, Dali University